fenofibrate has been researched along with Cardiac Diseases in 6 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "Omega-3 ensures a protective effect on cardiac diseases, arthrosis, elasticity of vessels, prolong the bleeding time, improve the theology of the blood, protect the endothelium by atherosclerosis, low heart rate and blood pressure, reduce the risk for cardiac arrhythmya, etc." | 2.73 | Which dose of omega-3 fatty acids must be taken in different cases of hypertriglyceridemia? ( Dondoi, C; Mogoş, T, 2008) |
| "Fenofibrate is a third-generation fibric acid derivative employed clinically as a hypolipidemic agent to lessen the risk caused by atherosclerosis." | 2.47 | Pleiotropic actions of fenofibrate on the heart. ( Balakumar, P; Mahadevan, N; Rohilla, A, 2011) |
| "fenofibrate treatment) in LT-associated cardiac injury." | 1.62 | Targeting PPARα in low ambient temperature exposure-induced cardiac dysfunction and remodeling. ( Chen, XY; Jiao, Y; Zhang, FY, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XY | 1 |
| Jiao, Y | 1 |
| Zhang, FY | 1 |
| Mogoş, T | 1 |
| Dondoi, C | 1 |
| Balakumar, P | 2 |
| Rohilla, A | 1 |
| Mahadevan, N | 1 |
| Grinspoon, S | 1 |
| Fitch, K | 1 |
| Jagadeesh, G | 1 |
| Ireland, JH | 1 |
| Eggert, CH | 1 |
| Arendt, CJ | 1 |
| Williams, AW | 1 |
1 review available for fenofibrate and Cardiac Diseases
| Article | Year |
|---|---|
Pleiotropic actions of fenofibrate on the heart.
Topics: Animals; Dyslipidemias; Fenofibrate; Heart; Heart Diseases; Humans; Hypolipidemic Agents; Treatment | 2011 |
1 trial available for fenofibrate and Cardiac Diseases
| Article | Year |
|---|---|
Which dose of omega-3 fatty acids must be taken in different cases of hypertriglyceridemia?
Topics: Dose-Response Relationship, Drug; Fatty Acids, Omega-3; Female; Fenofibrate; Heart Diseases; Humans; | 2008 |
4 other studies available for fenofibrate and Cardiac Diseases
| Article | Year |
|---|---|
Targeting PPARα in low ambient temperature exposure-induced cardiac dysfunction and remodeling.
Topics: Fenofibrate; Heart Diseases; Humans; PPAR alpha; Temperature | 2021 |
Therapy: HIV-associated dyslipidemia: the heart positive study.
Topics: Drug Therapy, Combination; Dyslipidemias; Exercise Therapy; Fenofibrate; Heart Diseases; HIV Infecti | 2011 |
PPAR ligands and cardiovascular disorders: friend or foe.
Topics: Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fenofibrate; Glucose; Heart | 2012 |
Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate.
Topics: Acute Kidney Injury; Female; Fenofibrate; Fluorobenzenes; Heart Diseases; Humans; Hydroxymethylgluta | 2005 |